Episode 73 – Oral Semaglutide in Obesity and Enoxaparin for Prevention of Deep Vein Thrombosis

Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!

This week, Drs. Mike and John Fralick discuss two recent papers exploring the role of oral semaglutide in patients with obesity and the efficacy of enoxaparin in preventing symptomatic venous thromboembolism in hospitalized older adults. Two papers, here we go!

  1. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial (0:00 – 10:50).

  2. Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients (10:50 – 18:46).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more